Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luis Concha

Showing results (131-140 of 165) with videos related to

Pageof 17
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 26, 2021
Improved post-stroke spontaneous recovery by astrocytic extracellular vesiclesYessica Heras-Romero, Axayacatl Morales-Guadarrama, Ricardo Santana-Martínez, et al.
Molecular Neurodegeneration|April 3, 2023
Cerebrospinal fluid lipoproteins inhibit α-synuclein aggregation by interacting with oligomeric species in seed amplification assaysGiovanni Bellomo, Silvia Paciotti, Luis Concha-Marambio, et al.
Acta Neuropathologica Communications|November 7, 2021
High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson's diseaseMarco J Russo, Christina D Orru, Luis Concha-Marambio, et al.
Acta Neuropathologica Communications|November 27, 2021
Correction to: High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson's diseaseMarco J Russo, Christina D Orru, Luis Concha-Marambio, et al.
Nature Communications|December 10, 2025
Seed amplification of MSA alpha-synuclein aggregates preserves the biological and structural properties of brain-derived aggregatesFei Wang, Victor Banerjee, Carla Barria, et al.
Medrxiv : the Preprint Server for Health Sciences|October 17, 2024
Misfolded alpha synuclein co-occurrence with Alzheimer's disease proteinopathyErin M Jonaitis, Karen MacLeod, Jennifer Lamoureux, et al.
Nature Communications|November 19, 2025
Personalized biomarkers of multiscale functional alterations in temporal lobe epilepsyKe Xie, Ella Sahlas, Alexander Ngo, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 13, 2025
Misfolded α-synuclein co-occurrence with Alzheimer's disease proteinopathyErin M Jonaitis, Karen MacLeod, Jennifer Lamoureux, et al.
Annals of Neurology|December 25, 2024
Staged Screening Identifies People with Biomarkers Related to Neuronal Alpha-Synuclein DiseaseEthan G Brown, Lana M Chahine, Andrew Siderowf, et al.
Nature Medicine|June 20, 2024
Target engagement and immunogenicity of an active immunotherapeutic targeting pathological α-synuclein: a phase 1 placebo-controlled trialPepijn Eijsvogel, Pinaki Misra, Luis Concha-Marambio, et al.
Pageof 17

Showing results (131-140 of 165) with videos related to

Sort By:
Pageof 17
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 26, 2021
Improved post-stroke spontaneous recovery by astrocytic extracellular vesiclesYessica Heras-Romero, Axayacatl Morales-Guadarrama, Ricardo Santana-Martínez, et al.
Molecular Neurodegeneration|April 3, 2023
Cerebrospinal fluid lipoproteins inhibit α-synuclein aggregation by interacting with oligomeric species in seed amplification assaysGiovanni Bellomo, Silvia Paciotti, Luis Concha-Marambio, et al.
Acta Neuropathologica Communications|November 7, 2021
High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson's diseaseMarco J Russo, Christina D Orru, Luis Concha-Marambio, et al.
Acta Neuropathologica Communications|November 27, 2021
Correction to: High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson's diseaseMarco J Russo, Christina D Orru, Luis Concha-Marambio, et al.
Nature Communications|December 10, 2025
Seed amplification of MSA alpha-synuclein aggregates preserves the biological and structural properties of brain-derived aggregatesFei Wang, Victor Banerjee, Carla Barria, et al.
Medrxiv : the Preprint Server for Health Sciences|October 17, 2024
Misfolded alpha synuclein co-occurrence with Alzheimer's disease proteinopathyErin M Jonaitis, Karen MacLeod, Jennifer Lamoureux, et al.
Nature Communications|November 19, 2025
Personalized biomarkers of multiscale functional alterations in temporal lobe epilepsyKe Xie, Ella Sahlas, Alexander Ngo, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 13, 2025
Misfolded α-synuclein co-occurrence with Alzheimer's disease proteinopathyErin M Jonaitis, Karen MacLeod, Jennifer Lamoureux, et al.
Annals of Neurology|December 25, 2024
Staged Screening Identifies People with Biomarkers Related to Neuronal Alpha-Synuclein DiseaseEthan G Brown, Lana M Chahine, Andrew Siderowf, et al.
Nature Medicine|June 20, 2024
Target engagement and immunogenicity of an active immunotherapeutic targeting pathological α-synuclein: a phase 1 placebo-controlled trialPepijn Eijsvogel, Pinaki Misra, Luis Concha-Marambio, et al.
Pageof 17